Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The Role and Real Effect of an Iterative Surgical Approach for the Management of Recurrent High-Grade Glioma: An Observational Analytic Cohort Study.

Salvati M, Pesce A, Palmieri M, Floriana Brunetto GM, Santoro A, Frati A.

World Neurosurg. 2019 Jan 3. pii: S1878-8750(18)32941-3. doi: 10.1016/j.wneu.2018.12.118. [Epub ahead of print]

PMID:
30610982
2.

Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.

Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.

Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.

PMID:
25434389
3.
4.

The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Aghi MK, Nahed BV, Sloan AE, Ryken TC, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):503-30. doi: 10.1007/s11060-015-1867-1. Epub 2015 Nov 3. Review.

PMID:
26530265
5.

Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.

Delgado-Fernandez J, Garcia-Pallero MÁ, Blasco G, Penanes JR, Gil-Simoes R, Pulido P, Sola RG.

World Neurosurg. 2017 Dec;108:610-617. doi: 10.1016/j.wneu.2017.09.062. Epub 2017 Sep 20.

PMID:
28939537
6.

Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.

Nitta M, Muragaki Y, Maruyama T, Ikuta S, Komori T, Maebayashi K, Iseki H, Tamura M, Saito T, Okamoto S, Chernov M, Hayashi M, Okada Y.

Neurosurg Focus. 2015 Jan;38(1):E7. doi: 10.3171/2014.10.FOCUS14651.

PMID:
25599276
7.

Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.

Fujii Y, Muragaki Y, Maruyama T, Nitta M, Saito T, Ikuta S, Iseki H, Hongo K, Kawamata T.

J Neurosurg. 2018 Jul;129(1):1-9. doi: 10.3171/2017.3.JNS162383. Epub 2017 Sep 8.

PMID:
28885120
8.

Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.

McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A.

Neurosurgery. 2008 Oct;63(4):700-7; author reply 707-8. doi: 10.1227/01.NEU.0000325729.41085.73.

PMID:
18981880
9.

GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status.

Pérez-Segura P, Manneh R, Ceballos I, García A, Benavides M, Fuster J, Vaz MA, Cano JM, Berros JP, Covela M, Moreno V, Quintanar T, García Bueno JM, Fernández I, Sepúlveda J.

Clin Transl Oncol. 2016 Aug;18(8):805-12. doi: 10.1007/s12094-015-1444-2. Epub 2015 Nov 5.

PMID:
26542177
10.

Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?

Palmer JD, Bhamidipati D, Song A, Eldredge-Hindy HB, Siglin J, Dan TD, Champ CE, Zhang I, Bar-Ad V, Kim L, Glass J, Evans JJ, Andrews DW, Werner-Wasik M, Shi W.

J Neurooncol. 2018 Dec;140(3):623-628. doi: 10.1007/s11060-018-2989-z. Epub 2018 Sep 4.

PMID:
30182159
11.

Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.

Rostomily RC, Spence AM, Duong D, McCormick K, Bland M, Berger MS.

Neurosurgery. 1994 Sep;35(3):378-88; discussion 388.

PMID:
7800129
12.

Antiangiogenic therapy for high-grade glioma.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N.

Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218.

PMID:
25242542
13.

Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.

Koo T, Lim DH, Seol HJ, Dho YS, Kim IH, Chang JH, Lee J, Jung TY, Gwak HS, Cho KH, Hong CK, Lee IJ, Kim E, Kim JH, Hong YK, Jang HS, Kim CY, Kim IA, Kim SH, Kim YI, Kim EY, Kim WC, Hong S.

J Neurooncol. 2018 Nov;140(2):445-455. doi: 10.1007/s11060-018-2972-8. Epub 2018 Aug 10.

PMID:
30097825
14.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
15.

High-grade glioma in children and adolescents: a single-center experience.

Yazici G, Zorlu F, Cengiz M, Ozyigit G, Eren G, Yüce D, Varan A, Akyuz C, Akalan N, Gurkaynak M.

Childs Nerv Syst. 2016 Feb;32(2):291-7. doi: 10.1007/s00381-015-2980-3. Epub 2015 Dec 17.

PMID:
26679932
16.

Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.

Guden M, Ayata HB, Ceylan C, Kilic A, Engin K.

Indian J Cancer. 2016 Jul-Sep;53(3):382-386. doi: 10.4103/0019-509X.200664.

17.

Management of supratentorial recurrent low-grade glioma: A multidisciplinary experience in 35 adult patients.

Spitaels J, Devriendt D, Sadeghi N, Luce S, De Witte O, Goldman S, Mélot C, Lefranc F.

Oncol Lett. 2017 Sep;14(3):2789-2795. doi: 10.3892/ol.2017.6543. Epub 2017 Jul 8.

18.

Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article.

Chang EF, Clark A, Jensen RL, Bernstein M, Guha A, Carrabba G, Mukhopadhyay D, Kim W, Liau LM, Chang SM, Smith JS, Berger MS, McDermott MW.

J Neurosurg. 2009 Aug;111(2):203-10. doi: 10.3171/2009.2.JNS081101.

PMID:
19267536
19.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

20.

Rechallenge temozolomide in glioma: A case series from India.

Patil VM, Tonse R, Kothari R, Chandrasekaran A, Pande N, Epari S, Gupta T, Jalali R.

Indian J Cancer. 2017 Jan-Mar;54(1):368-371. doi: 10.4103/ijc.IJC_173_17.

Supplemental Content

Support Center